Loading…

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families

Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutatio...

Full description

Saved in:
Bibliographic Details
Published in:Breast cancer research and treatment 2006-11, Vol.100 (1), p.83-91
Main Authors: GIANNINI, Giuseppe, CAPALBO, Carlo, RINALDI, Christian, ZANI, Massimo, FERRARO, Sergio, FRATI, Luigi, SCREPANTI, Isabella, GULINO, Alberto, RISTORI, Elisabetta, RICEVUTO, Enrico, SIDONI, Tina, BUFFONE, Amelia, CORTESI, Enrico, MARCHETTI, Paolo, SCAMBIA, Giovanni, TOMAO, Silverio
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193
cites cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193
container_end_page 91
container_issue 1
container_start_page 83
container_title Breast cancer research and treatment
container_volume 100
creator GIANNINI, Giuseppe
CAPALBO, Carlo
RINALDI, Christian
ZANI, Massimo
FERRARO, Sergio
FRATI, Luigi
SCREPANTI, Isabella
GULINO, Alberto
RISTORI, Elisabetta
RICEVUTO, Enrico
SIDONI, Tina
BUFFONE, Amelia
CORTESI, Enrico
MARCHETTI, Paolo
SCAMBIA, Giovanni
TOMAO, Silverio
description Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.
doi_str_mv 10.1007/s10549-006-9225-9
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68985706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68985706</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</originalsourceid><addsrcrecordid>eNpd0VFr1TAUB_AgirubfgBfJAj61u0kbZLmcV50DoaDoc8hTU-ko22uOe0Fv4Mfeu29Fwc-hIScXw6H_Bl7J-BSAJgrEqAqWwDowkqpCvuCbYQyZWGkMC_ZBoQ2ha5Bn7FzokcAsAbsa3YmdF0ZpWDD_n5Pe-z554ftteB-bA8nyX9hHvpuRD7Mk5-6NNKh6ImQaMBx4in-q3HaYZjyPBzMLuPe9zgG5N3Ibyffd37kTUZP0wquUuZp7_N6G_zCMo9-6PoO6Q17FX1P-Pa0X7CfX7_82H4r7u5vbrfXd0UolZ4KqXWjZBVja8umgcpj7VtZRq1EZcogMS6rBBA1YNBY2wDCtgtpLUYlbHnBPh377nL6PSNNbugoYN_7EdNMTte2Vgb0Aj_8Bx_TnMdlNieFrColZbUgcUQhJ6KM0e1yN_j8xwlwa07umJNbcnJrTm6d4P2p8dwM2D6_OAWzgI8n4Cn4Publpzp6drVUYGVZPgF5s5um</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212445224</pqid></control><display><type>article</type><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><source>Springer Nature</source><creator>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</creator><creatorcontrib>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</creatorcontrib><description>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</description><identifier>ISSN: 0167-6806</identifier><identifier>EISSN: 1573-7217</identifier><identifier>DOI: 10.1007/s10549-006-9225-9</identifier><identifier>PMID: 16847550</identifier><identifier>CODEN: BCTRD6</identifier><language>eng</language><publisher>Dordrecht: Springer</publisher><subject>Biological and medical sciences ; BRCA1 Protein - genetics ; BRCA2 Protein - genetics ; Breast cancer ; Breast Neoplasms - epidemiology ; Breast Neoplasms - etiology ; Breast Neoplasms - genetics ; Cancer research ; Female ; Female genital diseases ; Genes, BRCA1 ; Genes, BRCA2 ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Gynecology. Andrology. Obstetrics ; Humans ; Italy - epidemiology ; Male ; Mammary gland diseases ; Medical sciences ; Ovarian cancer ; Ovarian Neoplasms - epidemiology ; Ovarian Neoplasms - etiology ; Ovarian Neoplasms - genetics ; Pedigree ; Prevalence ; Tumors</subject><ispartof>Breast cancer research and treatment, 2006-11, Vol.100 (1), p.83-91</ispartof><rights>2006 INIST-CNRS</rights><rights>Springer Science+Business Media, LLC 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</citedby><cites>FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18250923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16847550$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GIANNINI, Giuseppe</creatorcontrib><creatorcontrib>CAPALBO, Carlo</creatorcontrib><creatorcontrib>RINALDI, Christian</creatorcontrib><creatorcontrib>ZANI, Massimo</creatorcontrib><creatorcontrib>FERRARO, Sergio</creatorcontrib><creatorcontrib>FRATI, Luigi</creatorcontrib><creatorcontrib>SCREPANTI, Isabella</creatorcontrib><creatorcontrib>GULINO, Alberto</creatorcontrib><creatorcontrib>RISTORI, Elisabetta</creatorcontrib><creatorcontrib>RICEVUTO, Enrico</creatorcontrib><creatorcontrib>SIDONI, Tina</creatorcontrib><creatorcontrib>BUFFONE, Amelia</creatorcontrib><creatorcontrib>CORTESI, Enrico</creatorcontrib><creatorcontrib>MARCHETTI, Paolo</creatorcontrib><creatorcontrib>SCAMBIA, Giovanni</creatorcontrib><creatorcontrib>TOMAO, Silverio</creatorcontrib><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><title>Breast cancer research and treatment</title><addtitle>Breast Cancer Res Treat</addtitle><description>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</description><subject>Biological and medical sciences</subject><subject>BRCA1 Protein - genetics</subject><subject>BRCA2 Protein - genetics</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - epidemiology</subject><subject>Breast Neoplasms - etiology</subject><subject>Breast Neoplasms - genetics</subject><subject>Cancer research</subject><subject>Female</subject><subject>Female genital diseases</subject><subject>Genes, BRCA1</subject><subject>Genes, BRCA2</subject><subject>Genetic Predisposition to Disease</subject><subject>Germ-Line Mutation</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Italy - epidemiology</subject><subject>Male</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Ovarian Neoplasms - etiology</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Pedigree</subject><subject>Prevalence</subject><subject>Tumors</subject><issn>0167-6806</issn><issn>1573-7217</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpd0VFr1TAUB_AgirubfgBfJAj61u0kbZLmcV50DoaDoc8hTU-ko22uOe0Fv4Mfeu29Fwc-hIScXw6H_Bl7J-BSAJgrEqAqWwDowkqpCvuCbYQyZWGkMC_ZBoQ2ha5Bn7FzokcAsAbsa3YmdF0ZpWDD_n5Pe-z554ftteB-bA8nyX9hHvpuRD7Mk5-6NNKh6ImQaMBx4in-q3HaYZjyPBzMLuPe9zgG5N3Ibyffd37kTUZP0wquUuZp7_N6G_zCMo9-6PoO6Q17FX1P-Pa0X7CfX7_82H4r7u5vbrfXd0UolZ4KqXWjZBVja8umgcpj7VtZRq1EZcogMS6rBBA1YNBY2wDCtgtpLUYlbHnBPh377nL6PSNNbugoYN_7EdNMTte2Vgb0Aj_8Bx_TnMdlNieFrColZbUgcUQhJ6KM0e1yN_j8xwlwa07umJNbcnJrTm6d4P2p8dwM2D6_OAWzgI8n4Cn4Publpzp6drVUYGVZPgF5s5um</recordid><startdate>20061101</startdate><enddate>20061101</enddate><creator>GIANNINI, Giuseppe</creator><creator>CAPALBO, Carlo</creator><creator>RINALDI, Christian</creator><creator>ZANI, Massimo</creator><creator>FERRARO, Sergio</creator><creator>FRATI, Luigi</creator><creator>SCREPANTI, Isabella</creator><creator>GULINO, Alberto</creator><creator>RISTORI, Elisabetta</creator><creator>RICEVUTO, Enrico</creator><creator>SIDONI, Tina</creator><creator>BUFFONE, Amelia</creator><creator>CORTESI, Enrico</creator><creator>MARCHETTI, Paolo</creator><creator>SCAMBIA, Giovanni</creator><creator>TOMAO, Silverio</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20061101</creationdate><title>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</title><author>GIANNINI, Giuseppe ; CAPALBO, Carlo ; RINALDI, Christian ; ZANI, Massimo ; FERRARO, Sergio ; FRATI, Luigi ; SCREPANTI, Isabella ; GULINO, Alberto ; RISTORI, Elisabetta ; RICEVUTO, Enrico ; SIDONI, Tina ; BUFFONE, Amelia ; CORTESI, Enrico ; MARCHETTI, Paolo ; SCAMBIA, Giovanni ; TOMAO, Silverio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>BRCA1 Protein - genetics</topic><topic>BRCA2 Protein - genetics</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - epidemiology</topic><topic>Breast Neoplasms - etiology</topic><topic>Breast Neoplasms - genetics</topic><topic>Cancer research</topic><topic>Female</topic><topic>Female genital diseases</topic><topic>Genes, BRCA1</topic><topic>Genes, BRCA2</topic><topic>Genetic Predisposition to Disease</topic><topic>Germ-Line Mutation</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Italy - epidemiology</topic><topic>Male</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Ovarian Neoplasms - etiology</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Pedigree</topic><topic>Prevalence</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GIANNINI, Giuseppe</creatorcontrib><creatorcontrib>CAPALBO, Carlo</creatorcontrib><creatorcontrib>RINALDI, Christian</creatorcontrib><creatorcontrib>ZANI, Massimo</creatorcontrib><creatorcontrib>FERRARO, Sergio</creatorcontrib><creatorcontrib>FRATI, Luigi</creatorcontrib><creatorcontrib>SCREPANTI, Isabella</creatorcontrib><creatorcontrib>GULINO, Alberto</creatorcontrib><creatorcontrib>RISTORI, Elisabetta</creatorcontrib><creatorcontrib>RICEVUTO, Enrico</creatorcontrib><creatorcontrib>SIDONI, Tina</creatorcontrib><creatorcontrib>BUFFONE, Amelia</creatorcontrib><creatorcontrib>CORTESI, Enrico</creatorcontrib><creatorcontrib>MARCHETTI, Paolo</creatorcontrib><creatorcontrib>SCAMBIA, Giovanni</creatorcontrib><creatorcontrib>TOMAO, Silverio</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Breast cancer research and treatment</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GIANNINI, Giuseppe</au><au>CAPALBO, Carlo</au><au>RINALDI, Christian</au><au>ZANI, Massimo</au><au>FERRARO, Sergio</au><au>FRATI, Luigi</au><au>SCREPANTI, Isabella</au><au>GULINO, Alberto</au><au>RISTORI, Elisabetta</au><au>RICEVUTO, Enrico</au><au>SIDONI, Tina</au><au>BUFFONE, Amelia</au><au>CORTESI, Enrico</au><au>MARCHETTI, Paolo</au><au>SCAMBIA, Giovanni</au><au>TOMAO, Silverio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families</atitle><jtitle>Breast cancer research and treatment</jtitle><addtitle>Breast Cancer Res Treat</addtitle><date>2006-11-01</date><risdate>2006</risdate><volume>100</volume><issue>1</issue><spage>83</spage><epage>91</epage><pages>83-91</pages><issn>0167-6806</issn><eissn>1573-7217</eissn><coden>BCTRD6</coden><abstract>Familial aggregations of breast/ovarian cancer cases frequently depend on BRCA1/2 pathogenic mutations. Here we counselled 120 Italian breast/ovarian cancer families and selected 73 probands for BRCA1/2 mutation screening. Through this analysis we defined the prevalence of BRCA1/2 pathogenic mutations occurring in Italian breast/ovarian cancer families, enlarged the spectrum of Italian BRCA1/2 mutations by 15% and report on the identification of 13 novel variants, including two deleterious truncating mutations and two potentially pathogenic missense mutations, on the BRCA1 and BRCA2 genes. Finally in hereditary breast cancer families with three or more female breast cancer cases we observed a low mutation prevalence and a significant association with BRCA2 mutations.</abstract><cop>Dordrecht</cop><pub>Springer</pub><pmid>16847550</pmid><doi>10.1007/s10549-006-9225-9</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-6806
ispartof Breast cancer research and treatment, 2006-11, Vol.100 (1), p.83-91
issn 0167-6806
1573-7217
language eng
recordid cdi_proquest_miscellaneous_68985706
source Springer Nature
subjects Biological and medical sciences
BRCA1 Protein - genetics
BRCA2 Protein - genetics
Breast cancer
Breast Neoplasms - epidemiology
Breast Neoplasms - etiology
Breast Neoplasms - genetics
Cancer research
Female
Female genital diseases
Genes, BRCA1
Genes, BRCA2
Genetic Predisposition to Disease
Germ-Line Mutation
Gynecology. Andrology. Obstetrics
Humans
Italy - epidemiology
Male
Mammary gland diseases
Medical sciences
Ovarian cancer
Ovarian Neoplasms - epidemiology
Ovarian Neoplasms - etiology
Ovarian Neoplasms - genetics
Pedigree
Prevalence
Tumors
title Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Novel%20BRCA1%20and%20BRCA2%20germline%20mutations%20and%20assessment%20of%20mutation%20spectrum%20and%20prevalence%20in%20Italian%20breast%20and/or%20ovarian%20cancer%20families&rft.jtitle=Breast%20cancer%20research%20and%20treatment&rft.au=GIANNINI,%20Giuseppe&rft.date=2006-11-01&rft.volume=100&rft.issue=1&rft.spage=83&rft.epage=91&rft.pages=83-91&rft.issn=0167-6806&rft.eissn=1573-7217&rft.coden=BCTRD6&rft_id=info:doi/10.1007/s10549-006-9225-9&rft_dat=%3Cproquest_cross%3E68985706%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-266b524ffd93bb04ae8ad23f651473c2efc2e300180ec6e89c019dad2d9ef5193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212445224&rft_id=info:pmid/16847550&rfr_iscdi=true